HIV resistance to raltegravir

di Clavel François
Pubblicazione 2009-11-01

HIV resistance to raltegravir

di Clavel, François
Pubblicazione 2009

Role of Gag in HIV Resistance to Protease Inhibitors

di Clavel, François, Mammano, Fabrizio
Pubblicazione 2010

Resistance-Associated Loss of Viral Fitness in Human Immunodeficiency Virus Type 1: Phenotypic Analysis of Protease and gag Coevolution in Protease Inhibitor-Treated Patients

di Mammano, Fabrizio, Petit, Caroline, Clavel, François
Pubblicazione 1998

Retracing the Evolutionary Pathways of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors: Virus Fitness in the Absence and in the Presence of Drug

di Mammano, Fabrizio, Trouplin, Virginie, Zennou, Veronique, Clavel, Francois
Pubblicazione 2000

Cytosolic Gag p24 as an Index of Productive Entry of Human Immunodeficiency Virus Type 1

di Maréchal, Valérie, Clavel, François, Heard, Jean Michel, Schwartz, Olivier
Pubblicazione 1998

Selective-Advantage Profile of Human Immunodeficiency Virus Type 1 Integrase Mutants Explains In Vivo Evolution of Raltegravir Resistance Genotypes

di Quercia, Romina, Dam, Elisabeth, Perez-Bercoff, Danielle, Clavel, François
Pubblicazione 2009

Delaying Reverse Transcription Does Not Increase Sensitivity of HIV-1 to Human TRIM5α

di Battivelli, Emilie, Lecossier, Denise, Clavel, François, Hance, Allan J.
Pubblicazione 2013

Kinetics of Antiviral Activity and Intracellular Pharmacokinetics of Human Immunodeficiency Virus Type 1 Protease Inhibitors in Tissue Culture

di Nascimbeni, Michelina, Lamotte, Claire, Peytavin, Gilles, Farinotti, Robert, Clavel, François
Pubblicazione 1999

Loss of Viral Fitness Associated with Multiple Gag and Gag-Pol Processing Defects in Human Immunodeficiency Virus Type 1 Variants Selected for Resistance to Protease Inhibitors I...

di Zennou, Véronique, Mammano, Fabrizio, Paulous, Sylvie, Mathez, Dominique, Clavel, François
Pubblicazione 1998

Impact of the HIV integrase genetic context on the phenotypic expression and in vivo dynamics of integrase inhibitor resistance mutations

di Nguyen, Nga, Rato, Sylvie, Clavel, Francois, Delaugerre, Constance, Mammano, Fabrizio
Pubblicazione 2013

Effects of Human Immunodeficiency Virus Type 1 Resistance to Protease Inhibitors on Reverse Transcriptase Processing, Activity, and Drug Sensitivity

di de la Carrière, Laurence Carron, Paulous, Sylvie, Clavel, François, Mammano, Fabrizio
Pubblicazione 1999

Effect of Cell Cycle Arrest on the Activity of Nucleoside Analogues against Human Immunodeficiency Virus Type 1

di Wurtzer, Sebastien, Compain, Séverine, Benech, Henri, Hance, Allan J., Clavel, François
Pubblicazione 2005

Extensive Recombination among Human Immunodeficiency Virus Type 1 Quasispecies Makes an Important Contribution to Viral Diversity in Individual Patients

di Charpentier, Charlotte, Nora, Tamara, Tenaillon, Olivier, Clavel, François, Hance, Allan J.
Pubblicazione 2006

Human Immunodeficiency Virus Type 1: Resistance to Nucleoside Analogues and Replicative Capacity in Primary Human Macrophages

di Perez-Bercoff, Danielle, Wurtzer, Sébastien, Compain, Séverine, Benech, Henri, Clavel, François
Pubblicazione 2007

Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type

di Matsuoka, Saori, Dam, Elisabeth, Lecossier, Denise, Clavel, François, Hance, Allan J
Pubblicazione 2009

Peptide P5 (residues 628–683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection

di Clavel François, Labrosse Beatrice, Alfsen Annette, Tudor Daniela, Yu Huifeng, Bomsel Morgane
Pubblicazione 2008-10-01

Peptide P5 (residues 628–683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection

di Yu, Huifeng, Tudor, Daniela, Alfsen, Annette, Labrosse, Beatrice, Clavel, François, Bomsel, Morgane
Pubblicazione 2008

Constrained Evolution of Human Immunodeficiency Virus Type 1 Protease during Sequential Therapy with Two Distinct Protease Inhibitors

di Dulioust, Anne, Paulous, Sylvie, Guillemot, Laurent, Delavalle, Anne-Marie, Boué, François, Clavel, François
Pubblicazione 1999

Human Immunodeficiency Virus Type 1 Variants Isolated from Single Plasma Samples Display a Wide Spectrum of Neutralization Sensitivity

di Skrabal, Katharina, Saragosti, Sentob, Labernardière, Jean-Louis, Barin, Francis, Clavel, François, Mammano, Fabrizio
Pubblicazione 2005